Shilpan Shah – Projects — Houston Methodist Scholars

View Scopus Profile

h-index

Research activity per year

4 Active
6 Not started

10 results

Active

Phase IB/II Study Combining All-Trans Retinoic Acid (ATRA) with Carfilzomib Based Therapy in Plasma Cell Myeloma Patients Refractory to Carfilzomib
Pingali, S. R., Ganguly, S., Mathur, S., Shah, S. & Yi, Q.
7/29/24 → …
Project: Clinical Trial
IMPACT ON SURVIVAL OF FAITH-BASED SPIRITUAL CARE OR PSYCHOTHERAPY COMBINED WITH PALLIATIVE CARE VERSUS PALLIATIVE CARE ALONE IN PATIENTS WITH NON-CURATIVE MALIGNANCIES
Mai, H. P., Abdelrahim, M., Chang, J. C., Ganguly, S., Heyne, K., Mathur, S., Niravath, P. A., Pingali, S. R., Shah, S., Sun, K., Venta, L. A. & Zhang, J.
6/19/24 → …
Project: Clinical Trial
Open-Label, Multicenter, Phase 1 Study to Assess the Safety of P-BCMA-ALLO1 in Subjects with Relapsed / Refractory Multiple Myeloma (MM)
Ganguly, S., Mai, H. P., Pingali, S. R. & Shah, S.
3/21/24 → …
Project: Clinical Trial
A Study Comparing Talquetamab in Combination With Daratumumab or in Combination With Daratumumab and Pomalidomide Versus Daratumumab in Combination With Pomalidomide and Dexamethasone in Participants With Relapsed or Refractory Multiple Myeloma
Ganguly, S., Mai, H. P., Petkova, J., Pingali, S. R. & Shah, S.
3/30/23 → …
Project: Clinical Trial
Not started

An Open-label Phase II Study to Investigate the Efficacy, Safety, and Pharmacokinetics of Tirabrutinib in Patients With Primary Central Nervous System Lymphoma (PCNSL)
Pingali, S. R. & Shah, S.
Project: Clinical Trial
A Phase 1 Study of SEA-CD70 in Myeloid Malignancies
Shah, S., Ganguly, S. & Pingali, S. R.
Project: Clinical Trial
A Phase 3 Open-Label, Randomized Study of Fixed Duration Pirtobrutinib (LOXO-305) Plus Venetoclax and Rituximab Versus Venetoclax and Rituximab in Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (BRUIN CLL-322)
Shah, S., Ganguly, S., Mai, H. P., Petkova, J., Pingali, S. R. & Rice, L.
Project: Clinical Trial
Open Label, Multi-center, Phase 1b/2 Clinical Trial to Evaluate the Safety and Efficacy of Autologous CAR BCMA T Cells (CT053) in Patients With Relapsed and/or Refractory Multiple Myeloma (LUMMICAR STUDY 2)
Ganguly, S., Mai, H. P., Petkova, J., Pingali, S. R. & Shah, S.
Project: Clinical Trial
Sample and Data Collection for Hematologic disorders section, Houston Methodist Cancer Center
Pingali, S. R., Ganguly, S., Heyne, K., Hu, C. A., Jin, M. M., Rice, L., Shah, S., Yang, J., Yi, Q. & Zieske, A. W.
Project: Clinical Trial
Circulating tumor DNA 5-hydroxymethylcytosine as a novel biomarker for cancers.
Li, Z., Abdelrahim, M., Chang, J. C., Darcourt, J., Pingali, S. R., Sahay, S., Shah, S., Singh, M., Zhang, J., Zhou, S. & Zu, Y.
Project: Clinical Trial